NASDAQ: ERASErasca Inc Stock Ownership - Who owns Erasca?
Insider buying vs selling
Have Erasca Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Ebun Garner | Chief Legal Officer | 2026-04-01 | 80,000 | $1.70 | $136.00kBuy |
| Ebun Garner | Chief Legal Officer | 2026-04-01 | 80,000 | $16.40 | $1.31MSell |
| Shannon Morris | Chief Medical Officer | 2026-03-04 | 20,000 | $15.04 | $300.76kSell |
| Shannon Morris | Chief Medical Officer | 2026-03-04 | 20,000 | $1.70 | $34.00kBuy |
| Ebun Garner | General Counsel Corp. Sec. | 2026-01-07 | 120,000 | $1.70 | $204.00kBuy |
| Ebun Garner | General Counsel Corp. Sec. | 2026-01-07 | 120,000 | $5.59 | $670.80kSell |
| Ebun Garner | General Counsel Corp. Sec. | 2025-12-15 | 3,902 | $1.19 | $4.66kBuy |
| David M. Chacko | CFO and CBO | 2025-12-15 | 17,793 | $1.19 | $21.24kBuy |
ERAS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ERAS insiders and whales buy or sell their stock.
ERAS Shareholders
What type of owners hold Erasca Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Jonathan E. Lim | 17.86% | 62,451,152 | $922.40M | Insider |
| Arch Venture Partners X LLC | 3.16% | 11,055,554 | $163.29M | Insider |
| Bihua Chen | 3.09% | 10,813,246 | $159.71M | Insider |
| Alexander W. Casdin | 0.19% | 667,724 | $9.86M | Insider |
| Lin Wei | 0.09% | 315,812 | $4.66M | Insider |
| David M. Chacko | 0.08% | 279,980 | $4.14M | Insider |
| James Arthur Bristol | 0.06% | 207,500 | $3.06M | Insider |
| Pratik S. Multani | 0.05% | 172,866 | $2.55M | Insider |
| Ebun Garner | 0.01% | 25,076 | $370.37k | Insider |
| Frazls | 0.01% | 24,975 | $368.88k | Institution |
ERAS vs Biotech Stocks
Erasca Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.